{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:34:01Z","timestamp":1786718041337,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0301-4738.187668","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T06:39:57Z","timestamp":1470206397000},"page":"440","source":"Crossref","is-referenced-by-count":7,"title":["Failure to initiate early insulin therapy - A risk factor for diabetic retinopathy in insulin users with Type 2 diabetes mellitus: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report number 35)"],"prefix":"10.4103","volume":"64","author":[{"given":"Tarun","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KushalS","family":"Delhiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RajivP G","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaitheeswaran","family":"Kulothungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.187668-1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/187152907782793581","article-title":"Relevance of the vascular effects of insulin in the rationale of its therapeutical use","author":"Anfossi","year":"2007","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"key-10.4103\/0301-4738.187668-2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrendo.2010.122","article-title":"Effect of systemic medications on onset and progression of diabetic retinopathy","author":"Silva","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"key-10.4103\/0301-4738.187668-3","doi-asserted-by":"crossref","unstructured":"Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 1998;116:874-86.","DOI":"10.1001\/archopht.116.7.874"},{"key":"key-10.4103\/0301-4738.187668-4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(83)92585-0","article-title":"Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics","author":"Lauritzen","year":"1983","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.187668-5","first-page":"356","article-title":"Effect of rapid glycemic control on progression of diabetic retinopathy","author":"Funatsu","year":"1992","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.187668-6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/1056-8727(92)90018-G","article-title":"Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control","author":"Agardh","year":"1992","journal-title":"J Diabetes Complications"},{"key":"key-10.4103\/0301-4738.187668-7","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/diacare.15.8.1002","article-title":"High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients","author":"Cignarelli","year":"1992","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.187668-8","first-page":"329","article-title":"Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus","author":"Wirta","year":"1999","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/0301-4738.187668-9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2337\/diab.40.12.1725","article-title":"Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes","author":"Dills","year":"1991","journal-title":"Diabetes"},{"key":"key-10.4103\/0301-4738.187668-10","first-page":"A progressive disease","article-title":"K.prospective diabetes study 16","author":"U","year":"6 ye","journal-title":"Overview of"},{"key":"key-10.4103\/0301-4738.187668-11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/CBI-120030045","article-title":"Ethical principles and standards for the conduct of human and animal biological rhythm research","author":"Touitou","year":"2004","journal-title":"Chronobiol Int"},{"key":"key-10.4103\/0301-4738.187668-12","first-page":"S106","article-title":"Tests of glycemia in diabetes","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.187668-13","first-page":"S3","article-title":"Summary of revisions for the 2007 clinical practice recommendations","author":"American","year":"2007","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.187668-14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0161-6420(86)33606-6","article-title":"An alternative method of grading diabetic retinopathy","author":"Klein","year":"1986","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.187668-15","first-page":"165","article-title":"United Kingdom Prospective Diabetes Study Group","author":"United","year":"1998","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0301-4738.187668-16","first-page":"3281","article-title":"Insulin-induced vascular endothelial growth factor expression in retina","author":"Lu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.187668-17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI0213776","article-title":"Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF","author":"Poulaki","year":"2002","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0301-4738.187668-18","first-page":"56","article-title":"The atherogenic lipid profile is associated with type 2 diabetes and some of its treatment modalities","author":"Lin","year":"2003","journal-title":"Diabetes Nutr Metab"},{"key":"key-10.4103\/0301-4738.187668-19","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1001\/archinte.160.21.3301","article-title":"Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: The Ohasama study","author":"Hozawa","year":"2000","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0301-4738.187668-20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ophtha.2008.09.010","article-title":"Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2","author":"Raman","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.187668-21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-07-0169","article-title":"Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training","author":"Praet","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0301-4738.187668-22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11892-013-0366-z","article-title":"Insulin use early in the course of type 2 diabetes mellitus: The ORIGIN trial","author":"Hanefeld","year":"2013","journal-title":"Curr Diab Rep"},{"key":"key-10.4103\/0301-4738.187668-23","first-page":"598","article-title":"Glycemic response to newly initiated diabetes therapies","author":"Karter","year":"2007","journal-title":"Am J Manag Care"},{"key":"key-10.4103\/0301-4738.187668-24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00273856","article-title":"Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes","author":"Unger","year":"1985","journal-title":"Diabetologia"},{"key":"key-10.4103\/0301-4738.187668-25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/er.2007-0023","article-title":"Glucolipotoxicity: Fuel excess and beta-cell dysfunction","author":"Poitout","year":"2008","journal-title":"Endocr Rev"},{"key":"key-10.4103\/0301-4738.187668-26","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1152\/ajpendo.2000.279.5.E997","article-title":"Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15","author":"Gleason","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:30:35Z","timestamp":1786714235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.187668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"alternative-id":["187668"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.187668","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}